Insider Stock Trading History of Turner Daniel K Iii


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Turner Daniel K Iii since year 2005. The trader's CIK number is 1280249. At the time of this reporting, Turner Daniel K Iii is the Director of Orexigen Therapeutics, Inc. . (stock ticker symbol OREX). See this page for all insider trading activities at Orexigen Therapeutics, Inc. .

Note that in the past TURNER DANIEL K III also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Turner Daniel K Iii since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-12-22 OREX Orexigen Therapeutics, Inc. Buy 57,204 1.45 82,945
2011-03-29 TSPT Novacea Inc Sale 130,000 8.17 1,061,840
2010-12-22 OREX Orexigen Therapeutics, Inc. Sale 51,943 8.25 428,529
2010-12-23 OREX Orexigen Therapeutics, Inc. Sale 48,057 .00 0
2010-12-10 OREX Orexigen Therapeutics, Inc. Sale 333,635 .00 0
2010-12-13 OREX Orexigen Therapeutics, Inc. Sale 266,365 .00 0
2010-03-18 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,500,000 6.38 9,573,000
2009-12-17 OREX Orexigen Therapeutics, Inc. Sale 100,000 7.55 755,000
2009-09-22 OREX Orexigen Therapeutics, Inc. Sale 100,000 10.22 1,021,800
2009-09-17 OREX Orexigen Therapeutics, Inc. Sale 100,000 9.28 927,999
2009-09-16 OREX Orexigen Therapeutics, Inc. Sale 40,904 8.92 365,068
2009-09-14 OREX Orexigen Therapeutics, Inc. Sale 23,395 9.00 210,601
2009-09-15 OREX Orexigen Therapeutics, Inc. Sale 135,701 8.96 1,216,288
2009-09-11 TSPT Novacea Inc Sale 10,450 12.59 131,544
2009-09-09 TSPT Novacea Inc Sale 35,030 13.16 460,889
2009-09-10 TSPT Novacea Inc Sale 30,574 13.00 397,584
2008-12-05 OREX Orexigen Therapeutics, Inc. Buy 300,000 3.46 1,038,300

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turner Daniel K Iii (Director of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.